The Cohorts · Quarterly vintage
Inception 2023-10-01 · 2.7 years held
Q4 2023 · Top 5.
On 2023-10-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q4 2023 · Top 5 · since inception
+89.4%
CAGR 26.5% annualised
S&P 500 · since inception
+80.8%
CAGR 24.3% annualised
Spread
+8.6%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | CVX | $148.19 | $1,425.97 | +886.2% | $173.63 | +17.2% | +3.4% | Read → |
| 2 | OXY | $59.24 | $417.03 | +556.2% | $51.82 | -12.5% | -2.5% | Read → |
| 3 | JPM | $135.19 | $1,242.91 | +555.5% | $325.22 | +140.6% | +28.1% | Read → |
| 4 | BAC | $24.97 | $203.41 | +471.0% | $56.20 | +125.0% | +25.0% | Read → |
| 5 | GOOGL | $132.99 | $879.03 | +470.3% | $368.03 | +176.7% | +35.3% | Read → |
Biggest contributors
Where the cohort earned its keep.
- GOOGL · $132.99 → $368.03+176.7%
- JPM · $135.19 → $325.22+140.6%
- BAC · $24.97 → $56.20+125.0%
Biggest detractors
Where the protocol got it wrong.
- OXY · $59.24 → $51.82-12.5%